These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22648722)

  • 21. MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial.
    Fezeu LK; Ducros V; Guéant JL; Guilland JC; Andreeva VA; Hercberg S; Galan P
    PLoS One; 2018; 13(5):e0193352. PubMed ID: 29813097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
    Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
    JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life.
    Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
    J Nutr Health Aging; 2011 Jan; 15(1):37-44. PubMed ID: 21267525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
    Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
    Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
    JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial.
    van Soest APM; van de Rest O; Witkamp RF; Cederholm T; de Groot LCPGM
    Eur J Nutr; 2022 Oct; 61(7):3731-3739. PubMed ID: 35704085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.
    Aisen PS; Schneider LS; Sano M; Diaz-Arrastia R; van Dyck CH; Weiner MF; Bottiglieri T; Jin S; Stokes KT; Thomas RG; Thal LJ;
    JAMA; 2008 Oct; 300(15):1774-83. PubMed ID: 18854539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
    Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
    Am J Clin Nutr; 2009 Feb; 89(2):641-51. PubMed ID: 19116322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acids for depression in adults.
    Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. n-3 Long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind, placebo-controlled intervention.
    Malan L; Baumgartner J; Calder PC; Zimmermann MB; Smuts CM
    Am J Clin Nutr; 2015 Mar; 101(3):668-79. PubMed ID: 25733652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined supplementation of vitamin B12 and omega-3 fatty acids across two generations improves cardiometabolic variables in rats.
    Khaire A; Rathod R; Randhir K; Kale A; Joshi S
    Food Funct; 2016 Sep; 7(9):3910-9. PubMed ID: 27528436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
    Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
    Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.